New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NDAQ;AAPL;BBRY;HD;GOOG;REGN;SNY;NVO;HEK;GMCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>
May 21, 2015
06:38 EDTNVONovo Nordisk rejects claims made by Baxter, Reuters says
Novo Nordisk (NVO) rejects claims made by Baxter (BAX) that the company used substances made by Baxter in its Novoeight haemophilia treatment, following Monday's ITC investigation announcement, reports Reuters, citing an email from Novo Nordisk. Reference Link
05:52 EDTAAPLTesla batteries may surpass $1B in sales faster than iPhone, Economic Times says
Subscribe for More Information
05:41 EDTAAPLUber poaches new legal counsel Sabrina Ross from Apple, Re/code reports
Subscribe for More Information
05:38 EDTAAPLApple Pay may launch in Europe sooner than expected, BGR reports
Subscribe for More Information
05:15 EDTSNY, REGNRegeneron, Sanofi announce positive topline results from sarilumab Phase 3 study
Subscribe for More Information
May 20, 2015
19:54 EDTAAPLApple streaming music service coming first to Russia, Billboard says
Subscribe for More Information
16:00 EDTAAPLOptions Update; May 20, 2015
iPath S&P 500 VIX Short-Term Futures up 3c to 19.19. Option volume leaders: AAPL AAL YHOO DAL FB BABA UAL BAC TWTR LUV C TSLA GE MU
11:13 EDTNDAQNASDAQ management to meet with Jefferies
Subscribe for More Information
10:57 EDTGMCRKeurig Green Mountain calls active
Subscribe for More Information
10:42 EDTHDLowe's price target lowered to $68 from $75 at Cantor
Subscribe for More Information
10:38 EDTGMCRRumor: Keurig Green Mountain active amid renewed Coke-Cola speculation
Shares of Keurig Green Mountain (GMCR) are active amid renewed speculation Coke-Cola (KO) will increase its stake in the company.
10:26 EDTNVOJanssen acquires licence from Novo Nordisk for autoimmune disease development
Novo Nordisk (NVO) announced it has signed an agreement with Janssen Biotech (JNJ) under which Janssen will acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases. The program targets modulation of certain immune cells via a cell surface receptor, specifically the NKG2D receptor. Terms of the agreement have not been disclosed.
10:00 EDTGMCROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Achillion (ACHN) downgraded on valuation at JMP Securities... Ashland (ASH) downgraded to Equal-Weight from Overweight at First Analysis... Bank of Nova Scotia (BNS) downgraded to Underperform from Neutral at BofA/Merrill... Braskem (BAK) downgraded to Neutral from Overweight at JPMorgan... Comerica (CMA) downgraded to Underperform at Baird... Crestwood Midstream (CMLP) downgraded to Neutral from Buy at Ladenburg... Fifth Third (FITB) downgraded to Neutral from Outperform at Baird... Keurig Green Mountain (GMCR) downgraded to Hold from Buy at Argus... Keysight Technologies (KEYS) downgraded to Neutral from Outperform at Baird... Leju (LEJU) downgraded to Underperform from Buy at CLSA... Marrone Bio (MBII) downgraded to Hold from Buy at Jefferies... Southwest (LUV) downgraded to Neutral from Buy at Buckingham... SunTrust (STI) downgraded to Market Perform from Outperform at Keefe Bruyette... Western Alliance (WAL) downgraded to Market Perform from Outperform at Keefe Bruyette.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:53 EDTREGNRegeneron price target raised to $560 from $500 at Argus
Argus increased its price target on Regeneron as the firm notes that the company has had positive pipeline and earnings news over the past year, and has increased its sales outlook. Argus thinks the company has a strong pipeline and keeps a Buy rating on the shares.
08:18 EDTGMCRKeurig Green Mountain downgraded at Argus on 2.0 brewer challenges
Subscribe for More Information
08:10 EDTHDHome Depot earnings growth supports upside from current levels, says UBS
UBS expects continued strong sales at Home Deport and said its strong earnings growth should support upside from current levels. The firm sees sturdy margins and and reiterated its Buy rating and $129 price target on Home Depot shares.
07:38 EDTREGNRegeneron price target raised to $600 from $525 at Canaccord
Canaccord raised its price target on Regeneron to $600 from $525 following positive top-line data for its Phase 2b study of dupilumab in adult patients with moderate-to-severe asthma. The firm sees the data as significant, as it reinforces the role of dupilumab and increases the potential future revenue stream for the company. Canaccord reiterated its Buy rating on Regeneron shares.
07:31 EDTGMCRKeurig Green Mountain downgraded to Hold from Buy at Argus
Subscribe for More Information
06:25 EDTGOOGGoogle seeks new partners for next-generation Nexus phones, DigiTimes reports
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use